종양학 분야 인공지능(AI) 시장 규모는 향후 수년간 비약적인 성장이 전망됩니다. 2029년까지 CAGR 33.9%로 성장할 전망이며, 76억 달러로 성장이 예측됩니다. 예측 기간의 성장은 전자 진료기록카드(EHR)와의 통합, 치료 의사결정 지원, 환자 참가 및 교육, 규제 지원, 표준화에서 용도 확대에 기인하고 있습니다. 예측 기간 주요 동향으로는 헬스케어에서 자연어 처리(NLP) 통합, 바이오마커 탐색에서의 AI 활용, 임상 도입에서의 설명 가능한 AI에 대한 주력, 집단 헬스케어에서의 AI 통합, AI 개발자와 헬스케어 공급자 간의 협업, 예측 분석의 진보 등이 있습니다.
암 이환율 증가는 암 분야 AI 시장의 확대를 추진하는 주요 요인이 될 것으로 예상됩니다. 암은 체내 이상 세포의 무질서한 증식 및 분열을 특징으로 하는 다면적인 질환군입니다. 종양학 분야 AI의 통합은 암 의료에 혁명을 가져오고 더 높은 정확도, 개별화, 효율성을 제공합니다. 예를 들면, 미국을 거점으로 하는 임의 단체인 미국암협회(American Cancer Society Inc.)의 보고서에 의하면, 2023년에는 새로운 암 환자가 180만 명에서 190만 명으로 증가한 것으로 평가되었습니다. 이처럼 암 환자 발생이 증가하고 있는 것이 암 분야 AI 시장의 성장을 뒷받침하고 있습니다.
제약 기업의 클라우드 기반 애플리케이션 및 서비스 이용이 확대됨에 따라 향후 종양학 분야 인공지능(AI) 시장의 성장을 가속할 것으로 예상됩니다. 종양학에서 이러한 클라우드 솔루션의 채용은, 그 많은 이점에 의해 착실하게 증가하고 있습니다. 클라우드 컴퓨팅을 통해 연구자는 게놈, 프로테오믹스, 메타볼로믹스, 스크립트믹스, 임상 및 역학 정보 등 광범위한 데이터 세트에 접근해 분석할 수 있습니다. 이 기능은 정밀 의료를 목표로 한 암 연구를 가속화하는 데 특히 유익합니다. 예를 들어 2024년 6월 영국에 거점을 둔 비정부기구 AAG IT Services는 2022년 조사 대상 조직의 89%가 스토리지와 워크로드에 멀티 클라우드 솔루션을 채택한 반면 단일 퍼블릭 클라우드를 사용한 것은 9%에 불과하고 단일 프라이빗 클라우드에 의존한 것은 2%였다고 보고했습니다. 이처럼 제약기업들의 클라우드 기반 애플리케이션과 서비스 채택이 증가하고 있는 것이 암 분야 AI 시장을 견인할 것으로 보입니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향 및 전략
제4장 시장-금리, 인플레이션, 지정학, 코로나, 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석 및 전략 분석 프레임워크
- 세계의 종양학 분야 인공지능 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인 및 억제요인)
- 최종 이용 산업의 분석
- 세계의 종양학 분야 인공지능(AI) 시장 : 성장률 분석
- 세계의 종양학 분야 인공지능(AI) 시장 실적 : 규모 및 성장(2019-2024년)
- 세계의 종양학 분야 인공지능(AI) 시장 예측 : 규모 및 성장(2024-2029년, 2034년)
- 세계의 종양학 분야 인공지능 전체 시장 규모(TAM)
제6장 시장 세분화
- 세계의 종양학 분야 인공지능(AI) 시장 : 컴포넌트별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 소프트웨어 솔루션
- 하드웨어
- 서비스
- 세계의 종양학 분야 인공지능(AI) 시장 : 치료 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 화학요법
- 방사선치료
- 면역요법
- 기타 치료의 유형
- 세계의 종양학 분야 인공지능(AI) 시장 : 암 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 유방암
- 폐암
- 전립선암
- 대장암
- 뇌종양
- 기타 암의 유형
- 세계의 종양학 분야 인공지능(AI) 시장 : 용도별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 암 검출
- 창약
- 의약품 개발
- 기타 용도
- 세계의 종양학 분야 인공지능(AI) 시장 : 최종 사용자별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 병원
- 진단센터
- 제약회사
- 연구기관
- 기타 최종 사용자
- 세계의 종양학 분야 인공지능(AI) 시장 : 소프트웨어 솔루션별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 진단 소프트웨어
- 치료 계획 소프트웨어
- 환자 관리 소프트웨어
- 데이터 분석 플랫폼
- 세계의 종양학 분야 인공지능(AI) 시장 : 하드웨어별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- AI 대응 화상 디바이스
- 고성능 컴퓨팅 시스템
- 웨어러블 헬스 모니터
- 세계의 종양학 분야 인공지능(AI) 시장 : 서비스 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 컨설팅 서비스
- 통합서비스
- 유지보수 및 지원 서비스
제7장 지역별 및 국가별 분석
- 세계의 종양학 분야 인공지능(AI) 시장 : 지역별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 세계의 종양학 분야 인공지능(AI) 시장 : 국가별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
- 종양학에서의 인공지능(AI) 시장 : 경쟁 구도
- 종양학 분야 인공지능(AI) 시장 : 기업 프로파일
- Azra AI 개요, 제품 및 서비스, 전략 및 재무 분석
- IBM Corporation 개요, 제품 및 서비스, 전략 및 재무 분석
- Siemens Healthcare GmbH 개요, 제품 및 서비스, 전략 및 재무 분석
- Intel Corporation 개요, 제품 및 서비스, 전략 및 재무 분석
- GE HealthCare 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
- NVIDIA Corporation
- Digital Diagnostics Inc.
- ConcertAI Inc.
- PathAI Inc.
- Median Technologies SA
- Kheiron Medical Technologies Ltd
- Hampton Research Inc.
- Tempus Labs Inc.
- PAIge AI Inc.
- Prognos Health Inc.
- Enlitic
- Inspirata Inc.
- Berg LLC
- Proscia Inc.
- Prognos Health Inc.
제32장 세계 시장 경쟁 벤치마킹 및 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문 및 전략
- 종양학 분야 인공지능(AI) 시장 : 새로운 기회를 제공하는 국가(2029년)
- 종양학 분야 인공지능(AI) 시장 : 새로운 기회를 제공하는 부문(2029년)
- 종양학 분야 인공지능(AI) 시장 : 성장 전략(2029년)
제36장 부록
AJY
Artificial intelligence in oncology involves the application of AI technologies and techniques to enhance cancer diagnosis, treatment, research, and patient care. The overarching objective is to improve outcomes for cancer patients by utilizing computational methods to identify patterns, predict outcomes, and support evidence-based decision-making throughout the entire spectrum of cancer care.
The key components of artificial intelligence in oncology encompass software solutions, hardware, and services. In the oncology field, software solutions leverage AI to enhance various aspects of cancer diagnosis, treatment, and research. These applications are relevant to different treatment types such as chemotherapy, radiotherapy, and immunotherapy, addressing various cancer types including breast cancer, lung cancer, prostate cancer, colorectal cancer, brain tumors, and others. The technology is utilized in applications such as cancer detection, drug discovery, and drug development, serving diverse end-users such as hospitals, diagnostic centers, pharmaceutical companies, research institutes, and others.
The artificial intelligence in oncology market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence in oncology market statistics, including artificial intelligence in the oncology industry global market size, regional shares, competitors with artificial intelligence in oncology market share, detailed artificial intelligence in oncology market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence in oncology industry. This artificial intelligence in oncology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The artificial intelligence in oncology market size has grown exponentially in recent years. It will grow from $1.78 billion in 2024 to $2.36 billion in 2025 at a compound annual growth rate (CAGR) of 32.4%. The growth in the historic period can be attributed to rising cancer incidence, data proliferation in healthcare, clinical trial optimization, demand for personalized medicine, efficiency in radiology and pathology.
The artificial intelligence in oncology market size is expected to see exponential growth in the next few years. It will grow to $7.6 billion in 2029 at a compound annual growth rate (CAGR) of 33.9%. The growth in the forecast period can be attributed to integration with electronic health records (EHR), expanded applications in treatment decision support, patient engagement and education, regulatory support, and standardization. Major trends in the forecast period include integration of natural language processing (NLP) in healthcare, utilization of ai in biomarker discovery, focus on explainable ai for clinical adoption, integration of ai in population health management, collaborations between ai developers and healthcare providers, advancements in predictive analytics.
The growing incidence of cancer cases is anticipated to be a key driver propelling the expansion of the AI in oncology market. Cancer represents a multifaceted group of diseases characterized by the unregulated proliferation and division of abnormal cells within the body. The integration of AI into oncology stands to revolutionize cancer care, offering greater precision, personalization, and efficiency. For example, in 2023, a report from the American Cancer Society Inc., a US-based voluntary health organization, indicated an estimated increase in new cancer cases from 1.8 million to 1.9 million. Thus, the escalating occurrence of cancer cases fuels the growth of the AI in oncology market.
The growing use of cloud-based applications and services by pharmaceutical companies is expected to fuel the growth of artificial intelligence (AI) in the oncology market moving forward. The adoption of these cloud solutions in oncology has been rising steadily due to their many advantages. Cloud computing allows researchers to access and analyze extensive data sets, including genomics, proteomics, metabolomics, transcriptomics, and clinical and epidemiological information. This capability has been particularly beneficial in accelerating cancer research aimed at precision medicine. For example, in June 2024, AAG IT Services, a UK-based non-governmental organization, reported that in 2022, 89% of the organizations surveyed employed multi-cloud solutions for their storage and workloads, while only 9% used a single public cloud and 2% depended on a single private cloud. Thus, the increasing adoption of cloud-based applications and services by pharmaceutical companies is set to drive the AI in oncology market.
Leading companies in the AI in oncology market are concentrating on the development of innovative software, including cloud-based solutions, to enhance their effectiveness and deliver improved outcomes. Cloud-based software plays a pivotal role in AI applications within oncology, offering a scalable, adaptable, and accessible platform for processing and analyzing extensive volumes of medical data. For instance, in March 2023, Illumina Inc., a US-based biotechnology company, introduced Connected Insights, a novel cloud-based software designed for tertiary analysis in oncology applications. By integrating external knowledge bases, Connected Insights streamlines result interpretation and reporting from various assay types, empowering laboratories to expand their utilization of Next-Generation Sequencing (NGS) and accelerate the clinical reporting turnaround time.
In May 2024, Lunit, a medical solutions company based in South Korea, acquired Volpara Health Technologies for $193 million. The goal of this acquisition is to establish a strong partnership in the cancer diagnostics sector, especially within the U.S. market. By leveraging their combined strengths, Lunit aims to enhance its AI-driven solutions for early cancer detection and improve patient care. Volpara Health Technologies is a healthcare software company located in New Zealand that develops and sells tools for the detection and diagnosis of breast cancer.
Major companies operating in the artificial intelligence in oncology market report are Azra AI, IBM Corporation, Siemens Healthcare GmbH, Intel Corporation, GE HealthCare, NVIDIA Corporation, Digital Diagnostics Inc., ConcertAI Inc., PathAI Inc., Median Technologies SA, Kheiron Medical Technologies Ltd., Hampton Research Inc., Tempus Labs Inc., Paige AI Inc., Prognos Health Inc., Enlitic, Inspirata Inc., Berg LLC, Proscia Inc., Prognos Health Inc., Deep 6 AI Inc., Ibex Medical Analytics, Nanox Imaging Ltd., Zebra Medical Vision, Globavir Biosciences Inc.
North America was the largest region in the AI in oncology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in oncology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the artificial intelligence in oncology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The artificial intelligence in oncology market consists of revenues earned by entities by providing services such as surgery, targeted therapy, and stem cell transplantation. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence in the oncology market also includes sales of edge devices, storage devices, field-programmable gate arrays (FPGA), and tensor processing units (TPU). Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Artificial Intelligence In Oncology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on artificial intelligence in oncology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for artificial intelligence in oncology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The artificial intelligence in oncology market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Component: Software Solutions; Hardware; Services
- 2) By Treatment Type: Chemotherapy; Radiotherapy; Immunotherapy; Other Treatment Types
- 3) By Cancer Type: Breast Cancer; Lung Cancer; Prostate Cancer; Colorectal Cancer; Brain Tumor; Other Cancer Types
- 4) By Application: Cancer Detection; Drug Discovery; Drug Development; Other Applications
- 5) By End-Users: Hospitals; Diagnostic Centers; Pharmaceutical Companies; Research Institutes; Other End Users
- Subsegments:
- 1) By Software Solutions: Diagnostic Software; Treatment Planning Software; Patient Management Software; Data Analytics Platforms
- 2) By Hardware: AI-Enabled Imaging Devices; High-Performance Computing Systems; Wearable Health Monitors
- 3) By Services: Consulting Services; Integration Services; Maintenance And Support Services
- Companies Mentioned: Azra AI; IBM Corporation; Siemens Healthcare GmbH; Intel Corporation; GE HealthCare
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Artificial Intelligence In Oncology Market Characteristics
3. Artificial Intelligence In Oncology Market Trends And Strategies
4. Artificial Intelligence In Oncology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Artificial Intelligence In Oncology Growth Analysis And Strategic Analysis Framework
- 5.1. Global Artificial Intelligence In Oncology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Artificial Intelligence In Oncology Market Growth Rate Analysis
- 5.4. Global Artificial Intelligence In Oncology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Artificial Intelligence In Oncology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Artificial Intelligence In Oncology Total Addressable Market (TAM)
6. Artificial Intelligence In Oncology Market Segmentation
- 6.1. Global Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Software Solutions
- Hardware
- Services
- 6.2. Global Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Chemotherapy
- Radiotherapy
- Immunotherapy
- Other Treatment Types
- 6.3. Global Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Breast Cancer
- Lung Cancer
- Prostate Cancer
- Colorectal Cancer
- Brain Tumor
- Other Cancer Types
- 6.4. Global Artificial Intelligence In Oncology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Cancer Detection
- Drug Discovery
- Drug Development
- Other Applications
- 6.5. Global Artificial Intelligence In Oncology Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Diagnostic Centers
- Pharmaceutical Companies
- Research Institutes
- Other End Users
- 6.6. Global Artificial Intelligence In Oncology Market, Sub-Segmentation Of Software Solutions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Diagnostic Software
- Treatment Planning Software
- Patient Management Software
- Data Analytics Platforms
- 6.7. Global Artificial Intelligence In Oncology Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- AI-Enabled Imaging Devices
- High-Performance Computing Systems
- Wearable Health Monitors
- 6.8. Global Artificial Intelligence In Oncology Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Consulting Services
- Integration Services
- Maintenance And Support Services
7. Artificial Intelligence In Oncology Market Regional And Country Analysis
- 7.1. Global Artificial Intelligence In Oncology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Artificial Intelligence In Oncology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Artificial Intelligence In Oncology Market
- 8.1. Asia-Pacific Artificial Intelligence In Oncology Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Artificial Intelligence In Oncology Market
- 9.1. China Artificial Intelligence In Oncology Market Overview
- 9.2. China Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Artificial Intelligence In Oncology Market
- 10.1. India Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Artificial Intelligence In Oncology Market
- 11.1. Japan Artificial Intelligence In Oncology Market Overview
- 11.2. Japan Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Artificial Intelligence In Oncology Market
- 12.1. Australia Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Artificial Intelligence In Oncology Market
- 13.1. Indonesia Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Artificial Intelligence In Oncology Market
- 14.1. South Korea Artificial Intelligence In Oncology Market Overview
- 14.2. South Korea Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Artificial Intelligence In Oncology Market
- 15.1. Western Europe Artificial Intelligence In Oncology Market Overview
- 15.2. Western Europe Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Artificial Intelligence In Oncology Market
- 16.1. UK Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Artificial Intelligence In Oncology Market
- 17.1. Germany Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Artificial Intelligence In Oncology Market
- 18.1. France Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Artificial Intelligence In Oncology Market
- 19.1. Italy Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Artificial Intelligence In Oncology Market
- 20.1. Spain Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Artificial Intelligence In Oncology Market
- 21.1. Eastern Europe Artificial Intelligence In Oncology Market Overview
- 21.2. Eastern Europe Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Artificial Intelligence In Oncology Market
- 22.1. Russia Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Artificial Intelligence In Oncology Market
- 23.1. North America Artificial Intelligence In Oncology Market Overview
- 23.2. North America Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Artificial Intelligence In Oncology Market
- 24.1. USA Artificial Intelligence In Oncology Market Overview
- 24.2. USA Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Artificial Intelligence In Oncology Market
- 25.1. Canada Artificial Intelligence In Oncology Market Overview
- 25.2. Canada Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Artificial Intelligence In Oncology Market
- 26.1. South America Artificial Intelligence In Oncology Market Overview
- 26.2. South America Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Artificial Intelligence In Oncology Market
- 27.1. Brazil Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Artificial Intelligence In Oncology Market
- 28.1. Middle East Artificial Intelligence In Oncology Market Overview
- 28.2. Middle East Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Artificial Intelligence In Oncology Market
- 29.1. Africa Artificial Intelligence In Oncology Market Overview
- 29.2. Africa Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Artificial Intelligence In Oncology Market Competitive Landscape And Company Profiles
- 30.1. Artificial Intelligence In Oncology Market Competitive Landscape
- 30.2. Artificial Intelligence In Oncology Market Company Profiles
- 30.2.1. Azra AI Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. IBM Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Siemens Healthcare GmbH Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Intel Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. GE HealthCare Overview, Products and Services, Strategy and Financial Analysis
31. Artificial Intelligence In Oncology Market Other Major And Innovative Companies
- 31.1. NVIDIA Corporation
- 31.2. Digital Diagnostics Inc.
- 31.3. ConcertAI Inc.
- 31.4. PathAI Inc.
- 31.5. Median Technologies SA
- 31.6. Kheiron Medical Technologies Ltd
- 31.7. Hampton Research Inc.
- 31.8. Tempus Labs Inc.
- 31.9. Paige AI Inc.
- 31.10. Prognos Health Inc.
- 31.11. Enlitic
- 31.12. Inspirata Inc.
- 31.13. Berg LLC
- 31.14. Proscia Inc.
- 31.15. Prognos Health Inc.
32. Global Artificial Intelligence In Oncology Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Artificial Intelligence In Oncology Market
34. Recent Developments In The Artificial Intelligence In Oncology Market
35. Artificial Intelligence In Oncology Market High Potential Countries, Segments and Strategies
- 35.1 Artificial Intelligence In Oncology Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Artificial Intelligence In Oncology Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Artificial Intelligence In Oncology Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
